MTSS1 and posterior cortical atrophy: For example, microRNA-547 has been reported to inhibit apoptosis and may be a novel prognostic and therapeutic target in the management of PCa recurrence.[5] Another microRNA, microRNA-96, was shown to promote the growth of PCa cells by suppressing MTSS1.[6] Another type of RNAs, that is, long noncoding RNAs (lncRNAs), are the focus of intensive research as current data suggest their potential in cancer diagnosis, prognosis, and therapy.